it will be a very good company.

Winston
2021-09-18

$AbCellera Biologics(ABCL)$  Under the terms of the agreement, Moderna will have the rights to develop and commercialize antibodies resulting from the collaboration. AbCellera will receive research payments and is eligible to receive from Moderna downstream clinical and commercial milestone payments and royalties on net sales of products. Look at it this way. Volume is now nearly 13 MILLION SHARES , whereas average is 2 MILLION so say 7 times usual trades. IF you can be GREEN on A red day !! Then it must be a very good company. Well I am " all in" on this one so pray to god that it is as good as I think.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法